The global In-vitro diagnostics market is expected to show high growth to a value of $42.57 billion in 2012.
Amy Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, is to give a keynote presentation concerning regulatory considerations & challenges for immunotherapeutic/diagnostic co-development at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA. Amy’s presentation highlights GSK’s approach to immunotherapy for cancer (Antigen-Specific Cancer [...]